Acarix AB (Acarix AB) Institutional Ownership : 0.01% (As of Jun. 20, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Acarix AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Acarix AB's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Acarix AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Acarix AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Acarix AB Institutional Ownership Historical Data

The historical data trend for Acarix AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acarix AB Institutional Ownership Chart

Acarix AB Historical Data

The historical data trend for Acarix AB can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01

Acarix AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Acarix AB (Acarix AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acarix AB (OTCPK:ACIXF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

ACARIX:Sweden 7AC:Germany

Address

World Trade Center Malmo, Jungmansgatan 12, Malmo, SWE, 211 19

Website

https://www.acarix.com

Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96% certainty.

Acarix AB (Acarix AB) Headlines

From GuruFocus

Acarix AB Corporate Call Transcript

By GuruFocus Research • 02-12-2024